Tyra Biosciences, Inc.
TYRA
$25.37
$0.351.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.38% | -35.95% | -38.70% | -33.37% | -30.86% |
| Total Depreciation and Amortization | -2.71% | 0.19% | 5.20% | 16.98% | 27.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.11% | 43.73% | 53.02% | 66.74% | 78.21% |
| Change in Net Operating Assets | 244.40% | -94.98% | -123.32% | -174.61% | -185.83% |
| Cash from Operations | -26.58% | -39.68% | -36.36% | -42.99% | -37.58% |
| Capital Expenditure | -142.72% | 60.33% | 78.77% | 92.86% | 92.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -201.30% | 5.14% | 174.28% | 118.16% | 130.17% |
| Cash from Investing | -201.73% | 5.50% | 173.64% | 118.03% | 129.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,927.38% | 3,852.96% | -96.00% | -97.96% | -97.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -736.65% | -- | 100.00% | 100.00% |
| Cash from Financing | 3,877.60% | 4,048.07% | -95.99% | -97.96% | -97.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,365.50% | 89.74% | -142.93% | 62.47% | 99.25% |